146 related articles for article (PubMed ID: 12094341)
1. Gemcitabine induction chemotherapy in non-small cell lung cancer.
Depierre A; Westeel V; Jacoulet P
Semin Oncol; 2002 Jun; 29(3 Suppl 9):55-60. PubMed ID: 12094341
[TBL] [Abstract][Full Text] [Related]
2. [New neoadjuvant approaches using gemcitabine in non-small-cell lung cancer].
Depierre A; Westeel V; Jacoulet P
Bull Cancer; 2002 Aug; 89 Spec No():S76-9. PubMed ID: 12449034
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer.
Scagliotti GV
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):15-9. PubMed ID: 10960940
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
Scagliotti GV; Pastorino U; Vansteenkiste JF; Spaggiari L; Facciolo F; Orlowski TM; Maiorino L; Hetzel M; Leschinger M; Visseren-Grul C; Torri V
J Clin Oncol; 2012 Jan; 30(2):172-8. PubMed ID: 22124104
[TBL] [Abstract][Full Text] [Related]
5. Overview of the role of neoadjuvant chemotherapy for early stage non-small cell lung cancer.
Depierre A; Westeel V
Semin Oncol; 2001 Aug; 28(4 Suppl 14):29-36. PubMed ID: 11605181
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer.
Rinaldi M; Crinò L
Lung Cancer; 2001 Dec; 34 Suppl 4():S25-30. PubMed ID: 11742699
[TBL] [Abstract][Full Text] [Related]
7. Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2
Zhong WZ; Chen KN; Chen C; Gu CD; Wang J; Yang XN; Mao WM; Wang Q; Qiao GB; Cheng Y; Xu L; Wang CL; Chen MW; Kang X; Yan W; Yan HH; Liao RQ; Yang JJ; Zhang XC; Zhou Q; Wu YL
J Clin Oncol; 2019 Sep; 37(25):2235-2245. PubMed ID: 31194613
[TBL] [Abstract][Full Text] [Related]
8. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
9. [Gemcitabine and cisplatin as induction therapy for patients with histologically proven stage IIIA-N2 non-small-cell bronchial cancer: a phase-II study of the EORTC Cooperative Group (EORTC 08955)].
Malayeri R; Huber H
Strahlenther Onkol; 2001 Apr; 177(4):223-4. PubMed ID: 11370560
[No Abstract] [Full Text] [Related]
10. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
Detterbeck FC; Socinski MA; Gralla RJ; Edelman MJ; Jahan TM; Loesch DM; Limentani SA; Govindan R; Zaman MB; Ye Z; Monberg MJ; Obasaju CK
J Thorac Oncol; 2008 Jan; 3(1):37-45. PubMed ID: 18166839
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer.
De Marinis F; Gebbia V; De Petris L
Ann Oncol; 2005 May; 16 Suppl 4():iv116-122. PubMed ID: 15923411
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
de Castria TB; da Silva EM; Gois AF; Riera R
Cochrane Database Syst Rev; 2013 Aug; (8):CD009256. PubMed ID: 23949842
[TBL] [Abstract][Full Text] [Related]
13. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
Van Zandwijk N; Smit EF; Kramer GW; Schramel F; Gans S; Festen J; Termeer A; Schlosser NJ; Debruyne C; Curran D; Giaccone G
J Clin Oncol; 2000 Jul; 18(14):2658-64. PubMed ID: 10894864
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approach.
Scagliotti GV; Novello S
Semin Oncol; 2003 Aug; 30(4 Suppl 10):13-8. PubMed ID: 12917816
[TBL] [Abstract][Full Text] [Related]
16. Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer.
Naim Younes R; Gross JL; Abrao FG; Rodrigues Pereira J
Minerva Chir; 2013 Apr; 68(2):169-74. PubMed ID: 23612230
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer.
Scagliotti GV; Novello S
Lung Cancer; 2002 Nov; 38 Suppl 2():S13-9. PubMed ID: 12431824
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.
Tibaldi C; Mazzoni E; Arcabasso G; D'Incecco A; Antonuzzo A; Menconi G; Falcone A
Clin Lung Cancer; 2009 Jan; 10(1):53-7. PubMed ID: 19289373
[TBL] [Abstract][Full Text] [Related]
19. What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Boudaya MS; Smadhi H; Marghli A; Charmiti F; Ouerghi S; Mohamed J; Brahem E; Smati B; Mestiri T; Kilani T
Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):432-6. PubMed ID: 24570525
[TBL] [Abstract][Full Text] [Related]
20. [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].
Souquet PJ; Gerinière L
Bull Cancer; 2002 Aug; 89 Spec No():S80-4. PubMed ID: 12449035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
